1. Home
  2. LASE vs RNTX Comparison

LASE vs RNTX Comparison

Compare LASE & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASE
  • RNTX
  • Stock Information
  • Founded
  • LASE 2019
  • RNTX 2001
  • Country
  • LASE United States
  • RNTX United States
  • Employees
  • LASE N/A
  • RNTX N/A
  • Industry
  • LASE Industrial Machinery/Components
  • RNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LASE Industrials
  • RNTX Health Care
  • Exchange
  • LASE Nasdaq
  • RNTX Nasdaq
  • Market Cap
  • LASE 29.3M
  • RNTX 28.0M
  • IPO Year
  • LASE 2022
  • RNTX N/A
  • Fundamental
  • Price
  • LASE $2.80
  • RNTX $1.15
  • Analyst Decision
  • LASE
  • RNTX Hold
  • Analyst Count
  • LASE 0
  • RNTX 1
  • Target Price
  • LASE N/A
  • RNTX N/A
  • AVG Volume (30 Days)
  • LASE 2.2M
  • RNTX 133.3K
  • Earning Date
  • LASE 11-13-2025
  • RNTX 11-13-2025
  • Dividend Yield
  • LASE N/A
  • RNTX N/A
  • EPS Growth
  • LASE N/A
  • RNTX N/A
  • EPS
  • LASE N/A
  • RNTX N/A
  • Revenue
  • LASE $6,938,027.00
  • RNTX N/A
  • Revenue This Year
  • LASE N/A
  • RNTX N/A
  • Revenue Next Year
  • LASE N/A
  • RNTX N/A
  • P/E Ratio
  • LASE N/A
  • RNTX N/A
  • Revenue Growth
  • LASE 89.34
  • RNTX N/A
  • 52 Week Low
  • LASE $1.71
  • RNTX $1.04
  • 52 Week High
  • LASE $19.80
  • RNTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • LASE 48.43
  • RNTX 45.62
  • Support Level
  • LASE $2.36
  • RNTX $1.07
  • Resistance Level
  • LASE $2.79
  • RNTX $1.25
  • Average True Range (ATR)
  • LASE 0.53
  • RNTX 0.14
  • MACD
  • LASE -0.05
  • RNTX -0.01
  • Stochastic Oscillator
  • LASE 30.36
  • RNTX 21.33

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

About RNTX Rein Therapeutics Inc. Common Stock

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.

Share on Social Networks: